Literature DB >> 8951154

Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues.

M Nishida1, A Hino, K Mori, T Matsumoto, T Yoshikubo, H Ishitsuka.   

Abstract

The antitumor activity of cytostatic 5'-deoxy-5-fluorouridine (5'-dFUrd) depends on its being converted to 5-fluorouracil (5-FUra) by the enzyme thymidine phosphorylase (dThdPase, EC 2.42.4). We prepared mouse anti-human dThdPase monoclonal antibodies to serve as tools for clinical studies with this drug. Partially purified dThdPase obtained form HCT116 human colon cancer cells grown in athymic mice was used as and antigen for the immunization of mice. Six hybridomas were cloned which produced anti-human dThdPase antibodies, as detected by Western blot analysis with human dThdPase. With these antibodies, we developed an ELISA method sensitive enough to measure dThdPase levels, even in tumor tissue samples weighing as little as 10 mg. In addition, one monoclonal antibody was suitable for immunologically staining the enzyme in tumor tissues. Thus, these anti-human dThdPase monoclonal antibodies could be used to measure levels of the enzyme in tumor cells, which is essential for the activation of 5'-dFUrd.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8951154     DOI: 10.1248/bpb.19.1407

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  20 in total

1.  Prognostic value of thymidine phosphorylase activity in liver tissue adjacent to hepatocellular carcinoma.

Authors:  Takahiro Ezaki; Toru Ikegami; Takashi Maeda; Tomomi Yamada; Teruyoshi Ishida; Makoto Hashizume; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2005-06       Impact factor: 3.402

2.  Thymidine phosphorylase expression in progression of cervical cancer: correlation with microvessel count, proliferating cell nuclear antigen, and apoptosis.

Authors:  R Fujiwaki; K Hata; K Iida; Y Maede; M Koike; K Miyazaki
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

3.  Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model.

Authors:  Suguru Harada; Mieko Yanagisawa; Saori Kaneko; Keigo Yorozu; Kaname Yamamoto; Yoichiro Moriya; Naoki Harada
Journal:  Mol Clin Oncol       Date:  2015-07-21

4.  Expression of platelet-derived endothelial cell growth factor and its potential role in up-regulation of angiogenesis in scarred kidneys secondary to urinary tract diseases.

Authors:  R Konda; H Sato; K Sakai; M Sato; S Orikasa; N Kimura
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  Variations in the expression of platelet-derived endothelial cell growth factor in human colorectal polyps.

Authors:  T Enomoto; M Kuranami; A Kakita
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

6.  Localization of thymidine phosphorylase in advanced gastric and colorectal cancer.

Authors:  Michiya Kobayashi; Ken Okamoto; Toyokazu Akimori; Naoshige Tochika; Tadashi Yoshimoto; Takehiro Okabayashi; Takeki Sugimoto; Keijiro Araki
Journal:  J Mol Histol       Date:  2004-01       Impact factor: 2.611

7.  Expression of thymidine phosphorylase by macrophages in colorectal cancer tissues.

Authors:  Ji-Min Zhang; Takayuki Mizoi; Ken-Ichi Shiiba; Iwao Sasaki; Seiki Matsuno
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

8.  Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression levels in tumor and normal tissue specimens of T3 human colorectal carcinoma.

Authors:  Atsushi Okita; Kazunori Tsukuda; Masakazu Murakami; Tetsuya Ota; Hiroyoshi Doihara; Manabu Suda; Tomoharu Nakano; Kinya Matsuoka; Eiji Suzuki; Minoru Naito; Akio Andou; Nobuyoshi Shimizu
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

9.  Increased cytotoxicity and bystander effect of 5-fluorouracil and 5-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase.

Authors:  A Evrard; P Cuq; J Ciccolini; L Vian; J P Cano
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

10.  Study protocol of the B-CAST study: a multicenter, prospective cohort study investigating the tumor biomarkers in adjuvant chemotherapy for stage III colon cancer.

Authors:  Megumi Ishiguro; Kenjiro Kotake; Genichi Nishimura; Naohiro Tomita; Wataru Ichikawa; Keiichi Takahashi; Toshiaki Watanabe; Tomohisa Furuhata; Ken Kondo; Masaki Mori; Yoshihiro Kakeji; Akiyoshi Kanazawa; Michiya Kobayashi; Masazumi Okajima; Ichinosuke Hyodo; Keiko Miyakoda; Kenichi Sugihara
Journal:  BMC Cancer       Date:  2013-03-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.